PSSCRA Now Accepting Applications for 2025 Cancer Research Prize
The Pershing Square Sohn Cancer Research Alliance (PSSCRA) is thrilled to announce that applications for the prestigious 2025 Pershing Square Sohn Cancer Prize are now open. This annual award is designed to support promising talents in cancer research by providing substantial funding to innovative scientists committed to making significant breakthroughs in this vital field. With a generous grant of $250,000 each year over a three-year period, the prize empowers six researchers annually who are based in the greater New York City area.
Promoting Scientific Innovation
The Pershing Square Sohn Cancer Prize plays a crucial role in encouraging early-career scientists to engage in visionary and potentially high-risk cancer research projects. This is often a time when traditional funding sources may be limited. The Prize serves as a vital lifeline for these researchers, enabling them to make meaningful contributions to the field. Bill Ackman, a trustee of the Pershing Square Foundation, has noted that many past winners have made remarkable advancements in cancer research, fostering a more collaborative and innovative research landscape.
Who Can Apply and How?
To qualify for this award, applicants should have between two and six years of experience leading their own laboratories as of the award commencement in July 2025. Furthermore, candidates must hold an advanced degree such as a PhD, MD, or MD-PhD and be affiliated with a research institution located in the greater New York City area. It's important to note that the deadline for submitting a Letter of Intent is quickly approaching, with a cutoff date in late October 2024. For more detailed information regarding the application process and eligibility criteria, be sure to check the official application submission portal.
Backing Scientists at Pivotal Moments
Since its founding, the PSSCRA has provided funding and support to 71 talented researchers from 13 esteemed academic institutions. This highly competitive Prize not only funds important research efforts but also connects winners with leaders in the pharmaceutical and biotech industries. This connection creates a unique opportunity for winners to showcase their work to diverse audiences, including those in scientific, business, and philanthropic communities.
Insights from Previous Winners
Many previous winners have expressed their gratitude for the financial support they received through the Pershing Square Sohn Cancer Prize. For example, David Simon, a 2024 Prize winner from Weill Cornell Medicine, emphasized how the funding transformed his project, which might have been abandoned due to lack of resources. Similarly, Christine Chio, a 2021 Prize recipient, noted that the award provided her with invaluable networking opportunities and a broader scientific outlook.
A Legacy of Dedication and Vision
As the Prize approaches its twelfth year, Olivia Tournay Flatto, President of The Pershing Square Foundation and Co-Founder of the PSSCRA, reaffirmed her commitment to fostering a diverse scientific community. This initiative goes beyond just funding; it highlights the high quality of applications and the steadfast dedication of the reviewers involved in the selection process.
About the Pershing Square Sohn Cancer Research Alliance
Since its establishment in 2013, the PSSCRA has committed over $43 million to cutting-edge cancer research. By promoting collaboration between academia and industry, the Alliance aims to drive innovations that could lead to life-saving treatments for cancer. Each year, the Pershing Square Sohn Cancer Prize recognizes early-career scientists who are engaged in groundbreaking cancer research, serving as a crucial acknowledgment of their work and potential.
Frequently Asked Questions
What is the Pershing Square Sohn Cancer Prize?
The Pershing Square Sohn Cancer Prize is an annual award that provides $250,000 each year for three years to promising researchers in cancer science based in the New York City area.
Who is eligible to apply for the Prize?
Applicants should have between 2 to 6 years of experience managing their own labs, hold an advanced degree like a PhD or MD, and be affiliated with a research institution in the New York area.
How many winners are chosen each year?
Each year, six recipients are awarded the Prize for their innovative and impactful research proposals.
What advantages do winners receive from the Prize?
Winners gain significant funding for their research and access exclusive networking opportunities with leaders in the industry.
When is the deadline for applications?
The deadline for submitting a Letter of Intent is in late October 2024. Interested applicants should visit the PSSCRA website for the exact date.
